Imidazopyrazines and pyrazolopyrimidines and their use as AMPA receptor modulators

US10513523B2 · kind B2 · utility

Assignee

• Janssen Pharmaceuticals, Inc. · BE

Inventors

• Michael K. Ameriks · San Diego, US
• Bradley M. Savall · San Diego, US
• Devin M. Swanson · Carlsbad, US
• Dongpei Wu · San Diego, US

Key dates

• Filing date: Apr 28, 2016
• Grant date: Dec 24, 2019
• Expiry date: Apr 28, 2036

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D277/62
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

Provided herein are compounds of Formula (I), and pharmaceutically acceptable salts, N-oxides, or solvates thereof,Also provided herein are pharmaceutical compositions, comprising compounds of Formula (I), and methods of using compounds of Formula (I).